Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/23/2022

Market Cap

1,469,951,482

Shares Outstanding

82,320,000

Weighted SO

82,324,331

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

GLUE --.--%

IVA --.--%

CGEM --.--%

CMPX --.--%

REPL --.--%

CRNX --.--%

PRTC --.--%

MRUS --.--%

Beta

0.0090

Last Div

0.0000

Range

5.633-26.35

Chg

-0.0600

Avg Vol

252708

Mkt Cap

1469951482

Exch

NASDAQ

Country

NL

Phone

31 35 206 2971

DCF Diff

11.3726

DCF

4.9274

Div Yield

0.0000

P/S

104.4634

EV Multiple

-5.5866

P/FV

3.9920

Div Yield %

0.0000

P/E

-8.8186

PEG

-0.1214

Payout

0.0000

Current Ratio

9.8297

Quick Ratio

9.8297

Cash Ratio

9.5064

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

138506.2226

CCC

-138506.2226

Gross Margin

0.9990

Op Margin

-13.6295

Pretax Margin

-12.4638

Net Margin

-12.4638

Eff Tax Rate

0.0176

ROA

-0.3926

ROE

-0.6634

ROCE

-0.4778

NI/EBT

1.0000

EBT/EBIT

0.9145

EBIT/Rev

-13.6295

Debt Ratio

0.0013

D/E

0.0015

LT Debt/Cap

0.0008

Total Debt/Cap

0.0014

Int Coverage

0.0000

CF/Debt

-218.7114

Equity Multi

1.1529

Rec Turnover

0.0000

Pay Turnover

0.0026

Inv Turnover

0.0000

FA Turnover

17.8572

Asset Turnover

0.0315

OCF/Share

-1.2978

FCF/Share

-1.3019

Cash/Share

4.5476

OCF/Sales

-8.7351

FCF/OCF

1.0032

CF Coverage

-218.7114

ST Coverage

-525.2812

CapEx Coverage

-315.6973

Div&CapEx Cov

-315.6973

P/BV

3.9920

P/B

3.9920

P/S

104.4634

P/E

-8.8186

P/FCF

-11.9212

P/OCF

-12.5829

P/CF

-12.5829

PEG

-0.1214

P/S

104.4634

EV Multiple

-5.5866

P/FV

3.9920

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 13, 22:16 NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares GlobeNewswire Inc. Dec 12, 02:37 NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants GlobeNewswire Inc. Oct 04, 20:30 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Benzinga Jan 16, 14:48 Cholesterol Player NewAmsterdam Pharma's Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says

Revenue Product Segmentation